PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Chatzidionysiou, Katerina
TI  - Efficacy of Different Doses of Rituximab for the Treatment of RA: Data from the CERERRA Collaboration
DP  - 2012 Sep 01
TA  - MD Conference Express
PG  - 11--12
VI  - 12
IP  - 9
4099  - http://mdc.sagepub.com/content/12/9/11.short
4100  - http://mdc.sagepub.com/content/12/9/11.full
AB  - The approved dose of rituximab for the treatment of rheumatoid arthritis (RA) is 1000 mg × 2, but some data have suggested similar clinical efficacy with rituximab 500 mg × 2. The objective of this analysis was to compare the efficacy of the 2 doses, given as first or second treatment courses. The data for this analysis were obtained from the European Collaborative Registries for the Evaluation of Rituximab in Rheumatoid Arthritis [CERERRA], which includes 10 European registries.